Diffusion Pharmaceuticals Inc. Gains 28.46%
Thu 14 May 20 at 05:30 PM
Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ) jumped higher at $1.02, a gain of 28.5%. On Wed 13 May 20, DFFN:NASDAQ touched a New 2-Week Intraday High of $0.86. The stock appeared on our News Catalysts scanner on Mon 27 Apr 20 at 05:11 PM in the 'BIOTECH' category. From Wed 29 Apr 20, the stock recorded 70.00% Up Days and 63.64% Green Days
About Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ)
Diffusion Pharmaceuticals Inc is a clinical stage biotechnology company focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy.
Top 10 Gainers:
- Applied DNA Sciences, Inc. (APDN:NASDAQ), 71.09%
- Glory Star New Media Group Holdings Limited (GSMG:NASDAQ), 45.49%
- Allogene Therapeutics, Inc. (ALLO:NASDAQ), 35.96%
- Conatus Pharmaceuticals Inc. (CNAT:NASDAQ), 29.34%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 28.46%
- Cellectis S.A. (CLLS:NASDAQ), 27.08%
- AIM ImmunoTech Inc. (AIM:NYSEMKT), 25.11%
- Entercom Communications Corp. (ETM:NYSE), 24.84%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 24.81%
- Genius Brands International, Inc. (GNUS:NASDAQ), 24.43%